Clinical trial
Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic…
NCT00334906 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00334906 |
|---|---|
| Title | Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease) |
| Official title | An Open-Label Exploratory Study With Memantine: Assessment of Selected Measures of Volumetric MRI and Cognition in Patients With Moderate Dementia of the Alzheimer's Type |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | memantine HCl |
| Enrollment | 75 |
| Start date | Jul 1, 2005 |
| Primary completion | Nov 1, 2007 |
| First posted | Jun 8, 2006 |
| Last update posted | Jan 7, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: